ArticleOncogene2025

RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer.

Kui Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.